UNSPSC 85704062: Supplement right tibia with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right tibia with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QUG47Z

UNSPSC 85704062 Supplement right tibia with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows no meaningful recent state and local procurement activity aligned with its surgical-procedure scope. The five recent opportunities posted under this code—inmate medical and pharmacy services in Georgia, pharmacy benefit management in Florida, virtual primary and urgent care in Florida, peer support services for behavioral health workers in California, and fire department medical director services in California—represent healthcare administration, management services, and clinical direction rather than orthopedic surgical procedures or tissue-based medical devices. None of the solicitations involve orthopedic implants, tibia supplementation, or endoscopic surgical supplies.

The mismatch between the code's nominal definition and actual procurement activity posted under it reflects a classification inconsistency rather than a live market opportunity. State and local buyers in Georgia, Florida, and California are actively procuring comprehensive healthcare services, pharmacy management, virtual care platforms, behavioral health support, and medical direction roles—all legitimate public-sector healthcare needs—but none of these align with the specific surgical procedure named in UNSPSC 85704062. Business development professionals should verify the correct code assignment with procurement offices before developing pursuit strategies, as this code does not currently signal demand for the orthopedic or tissue-engineering products and services its name describes.